Key Treatment Priorities Dr Ken Romeril Australian & NZ MRDR: - - PowerPoint PPT Presentation

▶

Apr 13, 2023 22 likes •109 views

Key Treatment Priorities Dr Ken Romeril Australian & NZ MRDR: 37 sites, 2600 patients registered New Zealand & international myeloma treatment options & pathways New ways of evaluating and monitoring disease Molecular

SLIDE 1

Key Treatment Priorities Dr Ken Romeril

SLIDE 2

Australian & NZ MRDR: 37 sites, 2600 patients registered

SLIDE 3

New Zealand & international myeloma treatment

ptions &

pathways

SLIDE 4

New ways of evaluating and monitoring disease

SLIDE 5

SLIDE 6

Molecular profiling

f myeloma cells

Treatment A Treatment B Treatment C Assessment for minimal residual disease Reduce treatment intensity Increase treatment intensity MRD positive MRD negative

SLIDE 7

Cyrille Touzeau and Philippe

Moreau. Blood 2016

127:971-976

SLIDE 8

Myeloma registrations in 2012-2016

Māori Pasifika Asian Eur/Other Total Total Registrations 194 111 81 1478 1864 Crude incidence rate* 5.53 7.59 2.93 9.86 8.20 Age std incidence* 7.19 10.13 3.51 5.05 5.19